LENSAR (NASDAQ:LNSR) Rating Lowered to “Sell” at Wall Street Zen

LENSAR (NASDAQ:LNSR – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday, Wall Street Zen reports.

LNSR has been the topic of a number of other research reports. Weiss Ratings upgraded shares of LENSAR from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, October 22nd. BTIG Research cut their target price on shares of LENSAR from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday, November 10th. Lake Street Capital restated a “buy” rating and issued a $13.00 price target on shares of LENSAR in a report on Thursday, August 13th. Finally, Loop Capital set a $11.00 price target on shares of LENSAR in a report on Monday, September 28th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, LENSAR has a consensus rating of “Hold” and a consensus price target of $11.00.

Check Out Our Latest Analysis on LENSAR

LENSAR Stock Performance

Shares of LNSR opened at $5.00 on Friday. The firm has a market cap of $61.47 million, a PE ratio of -12.50 and a beta of 1.03. LENSAR has a 52-week low of $4.30 and a 52-week high of $12.94. The business’s 50 day moving average price is $6.43 and its two-hundred day moving average price is $7.17.

LENSAR (NASDAQ:LNSR – Get Free Report) last announced its quarterly earnings data on Tuesday, November 10th. The company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.28). The company had revenue of $14.13 million for the quarter, compared to analyst estimates of $14.30 million. LENSAR had a return on equity of 1,254.25% and a net margin of 56.07%.

Hedge Funds Weigh In On LENSAR

A number of hedge funds have recently added to or reduced their stakes in the stock. Mink Brook Asset Management LLC bought a new stake in LENSAR during the 3rd quarter worth approximately $659,000. Marshall Wace LLP purchased a new stake in shares of LENSAR in the third quarter worth approximately $1,213,000. State of Wyoming bought a new position in shares of LENSAR in the third quarter valued at approximately $110,000. Engineers Gate Manager LP bought a new position in shares of LENSAR in the second quarter valued at approximately $63,000. Finally, Susquehanna International Group LLP bought a new position in shares of LENSAR in the second quarter valued at approximately $253,000. Institutional investors and hedge funds own 40.15% of the company’s stock.

About LENSAR

(Get Free Report)

LENSAR, Inc. develops and markets laser-based technology for ophthalmic surgery, with a focus on procedures used to treat cataracts. Its systems are designed to assist surgeons with key steps in cataract surgery, including the creation of incisions and the fragmentation of the eye’s natural lens. The company’s products include the ALLY Adaptive Cataract Treatment System and the LENSAR Laser System, which use imaging and software to support surgical planning and treatment. LENSAR also offers related software, accessories and services for ophthalmic practices and surgical facilities.

Further Reading

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.